A recent study from National Cheng Kung University Hospital in Taiwan has revealed that SGLT2 inhibitors may significantly reduce total cardiovascular events in high-risk patients with type 2 diabetes.
Using novel nanotechnology, researchers detected femtogram-level inflammatory cytokines in Long COVID patients' plasma 18 months post-infection that directly impaired cardiomyocyte function - potentially explaining persistent cardiac symptoms and offering new diagnostic possibilities.
Study finds ketogenic diet restored menstrual cycles in women with amenorrhea and altered menses in 85% of participants, independent of the significant weight loss seen in both diet groups.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Researchers found that hypertensive patients with constipation faced higher odds of major adverse cardiac events compared to those with normal bowel habits, even after controlling for traditional cardiovascular risk factors and medications.
In this 68-week trial, semaglutide not only achieved 13.7% weight reduction but also decreased NSAID use and improved walking distance by 42.6 meters compared to placebo in patients with knee osteoarthritis, suggesting potential benefits beyond weight loss.
In a study of 139,695 TAVR patients, those under 65 showed a striking 28.2% one-year readmission rate and nearly 10% mortality - ten times higher than their counterparts in previous low-risk trials, suggesting careful patient selection remains crucial for younger candidates.
VICTOR trial examines vericiguat’s impact on cardiovascular death and heart failure hospitalizations in 6,000 stable HFrEF patients receiving quadruple therapy.